![Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine](https://www.frontierspartnerships.org/files/Articles/10009/adar-01-10009-HTML-r4/image_m/adar-01-10009-g001.jpg)
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
![Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study | Neuropsychopharmacology Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1016%2FS0893-133X%2800%2900110-X/MediaObjects/41386_2000_Article_BF1395518_Fig1_HTML.jpg)
Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study | Neuropsychopharmacology
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
![The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder | Clinical Drug Investigation The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder | Clinical Drug Investigation](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40261-021-01032-7/MediaObjects/40261_2021_1032_Fig1_HTML.png)
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder | Clinical Drug Investigation
![A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40122-019-00143-6/MediaObjects/40122_2019_143_Fig1_HTML.png)
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers | Neuropsychopharmacology Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.npp.1300251/MediaObjects/41386_2003_Article_BF1300251_Fig1_HTML.gif)
Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers | Neuropsychopharmacology
![Table 1 from Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine. | Semantic Scholar Table 1 from Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ce5294b2baee273c42748400115deb9255da5bec/2-Table1-1.png)
Table 1 from Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine. | Semantic Scholar
![JCM | Free Full-Text | Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder JCM | Free Full-Text | Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder](https://www.mdpi.com/jcm/jcm-10-03727/article_deploy/html/images/jcm-10-03727-g001-550.jpg)